Clinical Endocrinology NewsDenosumab's Bone Benefits Persist at 5 Years of TherapyMay 1, 2011Osteoporosis
Clinical Endocrinology NewsDenosumab Curbs Fractures Equally at All Risk LevelsApril 1, 2011Osteoporosis
Clinical Endocrinology NewsZoledronic Acid Cuts Fractures at All Risk LevelsMarch 1, 2011Osteoporosis
Clinical Endocrinology NewsDenosumab Gains New Indication, for Bone MetastasesFebruary 1, 2011Osteoporosis
Clinical Endocrinology NewsLocal Corticosteroids Slowed RA Hand Bone LossFebruary 1, 2011Osteoporosis
Clinical Endocrinology NewsTargeted Interventions Improve Hip Fracture OutcomesFebruary 1, 2011Osteoporosis
Clinical Endocrinology NewsVisceral Obesity Linked to Osteoporosis Before MenopauseJanuary 1, 2011Osteoporosis
Clinical Endocrinology NewsShort-Acting Opioids Up Fracture Risk in ElderlyJanuary 1, 2011Osteoporosis
